HealthQuill disease progression
Daiichi Sankyo and Merck & Co., Inc. will initiate talks with global regulatory agencies after an end-stage trial of its drug for a form of lung cancer improved patientsā€™ chances of extending survival without the disease progressing.
Drugs Health Pharma

Daiichi Sankyo-Merckā€™s trial lung cancer drug meets primary goal

Daiichi Sankyo and Merck & Co., Inc. will initiate talks with global regulatory agencies after an end-stage trial of its drug for a.

Read More
Switzerlandā€™s Novartis AG has received accelerated approval from the USFDA for its drug to reduce elevated levels of proteins in the urine of patients with a rare type of kidney disease.
Drugs Health Pharma

Novartisā€™s drug to treat rare kidney disease gets USFDA approvalĀ 

Switzerlandā€™s Novartis AG has received accelerated approval from the USFDA for its drug to reduce elevated levels of proteins in the urine of.

Read More
ALS
Drugs Health Medical

Parkinson’s drug Ropinirole shows promise as potential treatment for ALS, study finds

HQ Team June 7, 2023: Ropinirole, a drug already approved for the treatment of Parkinson’s disease, has shown potential as a treatment for.

Read More